Cargando…
Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063172/ https://www.ncbi.nlm.nih.gov/pubmed/26602179 http://dx.doi.org/10.1002/pds.3918 |
| _version_ | 1782459922097635328 |
|---|---|
| author | Mahaux, Olivia Bauchau, Vincent Van Holle, Lionel |
| author_facet | Mahaux, Olivia Bauchau, Vincent Van Holle, Lionel |
| author_sort | Mahaux, Olivia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5063172 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50631722016-10-19 Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines Mahaux, Olivia Bauchau, Vincent Van Holle, Lionel Pharmacoepidemiol Drug Saf Commentaries John Wiley and Sons Inc. 2015-11-25 2016-02 /pmc/articles/PMC5063172/ /pubmed/26602179 http://dx.doi.org/10.1002/pds.3918 Text en © 2015 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentaries Mahaux, Olivia Bauchau, Vincent Van Holle, Lionel Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines |
| title | Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
|
| title_full | Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
|
| title_fullStr | Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
|
| title_full_unstemmed | Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
|
| title_short | Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
|
| title_sort | pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063172/ https://www.ncbi.nlm.nih.gov/pubmed/26602179 http://dx.doi.org/10.1002/pds.3918 |
| work_keys_str_mv | AT mahauxolivia pharmacoepidemiologicalconsiderationsinobservedtoexpectedanalysesforvaccines AT bauchauvincent pharmacoepidemiologicalconsiderationsinobservedtoexpectedanalysesforvaccines AT vanhollelionel pharmacoepidemiologicalconsiderationsinobservedtoexpectedanalysesforvaccines |